IRulya Therapeutics Inc. has filed a Form 144 to sell 3,700 shares of common stock, signaling liquidity and strategic capital management.
| Name | IRulya Therapeutics Inc. |
|---|---|
| CIK | 0001662774 |
| Tickers | IRLA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 901024039 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 203-208-8994 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
IRulya Therapeutics Inc. has filed a Form 144 to sell 3,700 shares of common stock, signaling liquidity and strategic capital management.
IRulya Therapeutics Inc. unveils its latest corporate presentation, emphasizing innovations in rare disease treatments and the LAM-001 drug candidate.
IRulya Therapeutics Inc. files Form 3, appointing John Militello as Chief Financial Officer, signaling leadership stability in the biological products sector.
IRulya Therapeutics Inc. files Form 3, indicating a change in ownership involving director Leone D. Patterson, signaling potential management shifts.
Quince Therapeutics appoints new CEO and CFO, rebrands to IRulya Therapeutics, signaling a strategic shift in the biological products sector.
Quince Therapeutics gains stockholder approval for its 2026 Equity Incentive Plan and Employee Stock Purchase Plan, increasing authorized shares to 275 million.
Quince Therapeutics announces leadership changes with resignations and new appointments ahead of a critical stockholder meeting.
475 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | S-8 | S-8 | 0001193125-26-468531 | 333-300160 | 261574713 | 33 | 413283 | 1 | 1 | |
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001778253-26-000009 | 005-91007 | 261563725 | 34 | 164210 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-128354 | 005-91007 | 261561392 | 34 | 9344 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002050709-26-000035 | 005-91007 | 261558409 | 34 | 81140 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-005046 | 005-91007 | 261555086 | 34 | 16441 | |||
| 2026-11-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-127344 | 005-91007 | 261554785 | 34 | 9299 | |||
| 2026-11-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-460775 | 001-38890 | 261553109 | 34 | 210949 | 1 | 1 |
| 2026-11-13 | 10-Q | 10-Q | 0001193125-26-460562 | 001-38890 | 261552196 | 34 | 17063555 | 1 | 1 | |
| 2026-11-12 | 4 | xslF345X06/form4-11122026_041110.xml | 0001930805-26-000006 | 5867 | ||||||
| 2026-11-12 | 4 | xslF345X06/form4-11122026_041108.xml | 0002159117-26-000004 | 5938 | ||||||
| 2026-11-12 | 4 | xslF345X06/form4-11122026_041105.xml | 0001233539-26-000005 | 5871 | ||||||
| 2026-11-12 | 4 | xslF345X06/form4-11122026_041103.xml | 0002159407-26-000004 | 5940 | ||||||
| 2026-11-12 | 4 | xslF345X06/form4-11122026_041101.xml | 0001662170-26-000004 | 5681 | ||||||
| 2026-11-05 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-070962 | 001-38890 | 261526909 | 33 | 9939 | |||
| 2026-10-21 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-066751 | 001-38890 | 261476614 | 33 | 4671 | |||
| 2026-10-19 | 3 | xslF345X06/form3-10192026_081001.xml | 0002159407-26-000002 | 8666 | ||||||
| 2026-10-19 | 3 | xslF345X06/form3-10192026_081004.xml | 0002159117-26-000002 | 8663 | ||||||
| 2026-10-19 | 3 | xslF345X06/form3-10192026_081051.xml | 0001930805-26-000004 | 8582 | ||||||
| 2026-10-19 | 3 | xslF345X06/form3-10192026_081047.xml | 0001662170-26-000002 | 8600 | ||||||
| 2026-10-19 | 3 | xslF345X06/form3-10192026_081042.xml | 0002159394-26-000002 | 30598 | ||||||
| 2026-10-19 | 3 | xslF345X06/form3-10192026_081007.xml | 0001233539-26-000003 | 8586 | ||||||
| 2026-10-19 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-424731 | 001-38890 | 261467627 | 34 | 3881128 | 1 | 1 |
| 2026-10-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-115859 | 005-91007 | 261460334 | 34 | 19255 | |||
| 2026-10-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-421651 | 005-91007 | 261459952 | 34 | 12420 | |||
| 2026-10-09 | 8-K | 8-K | 5.02,5.03,7.01,8.01,9.01 | 0001193125-26-418538 | 001-38890 | 261451158 | 34 | 476031 | 1 | 1 |
| 2026-10-08 | S-8 | S-8 | 0001193125-26-418091 | 333-299377 | 261450606 | 33 | 424768 | 1 | 1 | |
| 2026-10-06 | 8-K | 8-K | 5.02,5.03,5.07,9.01 | 0001193125-26-415730 | 001-38890 | 261444741 | 34 | 567687 | 1 | 1 |
| 2026-10-02 | DEFA14A | DEFA14A | 0001193125-26-411262 | 001-38890 | 261433423 | 34 | 33225 | |||
| 2026-10-02 | 8-K | 8-K | 5.02 | 0001193125-26-411260 | 001-38890 | 261433420 | 34 | 162361 | 1 | 1 |
| 2026-09-14 | 8-K | 8-K | 2.01,5.02,9.01 | 0001193125-26-390652 | 001-38890 | 261377726 | 34 | 677882 | 1 | 1 |
| 2026-09-04 | 8-K | 8-K | 3.01 | 0001193125-26-382838 | 001-38890 | 261360209 | 34 | 140102 | 1 | 1 |
| 2026-08-27 | 8-K | 8-K | 5.02 | 0001193125-26-371389 | 001-38890 | 261331026 | 34 | 137278 | 1 | 1 |
| 2026-08-25 | DEF 14A | DEF 14A | 0001193125-26-364220 | 001-38890 | 261312445 | 34 | 4657735 | 1 | 1 | |
| 2026-08-24 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002741 | 333-297903 | 261312280 | 33 | 1863 | ||
| 2026-08-17 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-353141 | 001-38890 | 261284622 | 34 | 202739 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-352966 | 005-91007 | 261284480 | 34 | 154523 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097291 | 005-91007 | 261283052 | 34 | 10981 | |||
| 2026-08-14 | 10-Q | 10-Q | 0001193125-26-352201 | 001-38890 | 261281284 | 34 | 16885851 | 1 | 1 | |
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003692 | 005-91007 | 261279707 | 34 | 12023 | |||
| 2026-08-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-350568 | 001-38890 | 261276336 | 34 | 209918 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003433 | 005-91007 | 261275842 | 34 | 16382 | |||
| 2026-08-05 | S-3/A | S-3/A | 0001193125-26-333764 | 333-297903 | 261241191 | 33 | 78438 | |||
| 2026-08-04 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002050709-26-000021 | 005-91007 | 261237864 | 34 | 80814 | |||
| 2026-07-31 | 8-K | 8-K | 5.02 | 0001193125-26-328784 | 001-38890 | 261229251 | 34 | 152473 | 1 | 1 |
| 2026-07-31 | PRE 14A | PRE 14A | 0001193125-26-328777 | 001-38890 | 261229239 | 34 | 4957670 | 1 | 1 | |
| 2026-07-31 | S-3 | S-3 | 0001193125-26-328769 | 333-297903 | 261229219 | 33 | 719098 | 1 | 1 | |
| 2026-07-30 | 8-K/A | 8-K/A | 8.01,9.01 | 0001193125-26-324786 | 001-38890 | 261219948 | 34 | 2530048 | 1 | 1 |
| 2026-06-26 | 8-K/A | 8-K/A | 3.03 | 0001193125-26-285572 | 001-38890 | 261129865 | 34 | 147496 | 1 | 1 |
| 2026-06-26 | 8-K | 8-K | 3.03,5.03,9.01 | 0001193125-26-284089 | 001-38890 | 261124176 | 34 | 158020 | 1 | 1 |
| 2026-06-15 | 4 | FORM 4 | 0000912282-26-000832 | 5438 | ||||||
| 2026-06-15 | 4 | FORM 4 | 0000912282-26-000830 | 5456 | ||||||
| 2026-06-11 | 4 | xslF345X06/form4-06112026_090603.xml | 0001346566-26-000004 | 25538 | ||||||
| 2026-06-11 | 3 | xslF345X06/form3-06112026_090601.xml | 0001346566-26-000003 | 11091 | ||||||
| 2026-06-11 | 8-K | 8-K | 5.07 | 0001193125-26-267862 | 001-38890 | 261084028 | 34 | 151879 | 1 | 1 |
| 2026-06-11 | D | xslFormDX01/primary_doc.xml | 06b | 0000912282-26-000811 | 021-587011 | 261082204 | 33 | 11544 | ||
| 2026-06-11 | D | xslFormDX01/primary_doc.xml | 06b | 0000912282-26-000809 | 021-587010 | 261082203 | 33 | 11354 | ||
| 2026-06-10 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-072388 | 005-91007 | 261080253 | 34 | 20092 | |||
| 2026-05-21 | 8-K | 8-K | 8.01 | 0001193125-26-234858 | 001-38890 | 261009765 | 34 | 137835 | 1 | 1 |
| 2026-05-18 | 8-K/A | 8-K/A | 7.01,9.01 | 0001193125-26-228956 | 001-38890 | 26993645 | 34 | 182695 | 1 | 1 |
| 2026-05-18 | 8-K | 8-K | 1.01,2.01,3.02,5.02,5.03,7.01,9.01 | 0001193125-26-228133 | 001-38890 | 26991089 | 34 | 6136170 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-062688 | 005-91007 | 26988871 | 34 | 11172 | |||
| 2026-05-11 | 10-Q | 10-Q | 0001193125-26-217098 | 001-38890 | 26964399 | 34 | 11938607 | 1 | 1 | |
| 2026-04-28 | 8-K | 8-K | 8.01 | 0001193125-26-187243 | 001-38890 | 26908356 | 34 | 138654 | 1 | 1 |
| 2026-04-27 | ARS | ARS | 0001193125-26-182282 | 001-38890 | 26901671 | 34 | 1241213 | |||
| 2026-04-27 | DEFA14A | DEFA14A | 0001193125-26-182267 | 001-38890 | 26901652 | 34 | 933263 | 1 | 1 | |
| 2026-04-27 | DEF 14A | DEF 14A | 0001193125-26-182255 | 001-38890 | 26901638 | 34 | 5621139 | 1 | 1 | |
| 2026-04-22 | 8-K | 8-K | 5.02 | 0001193125-26-170572 | 001-38890 | 26884223 | 34 | 139991 | 1 | 1 |
| 2026-04-17 | PRE 14A | PRE 14A | 0001193125-26-161838 | 001-38890 | 26872718 | 34 | 5392976 | 1 | 1 | |
| 2026-04-17 | S-8 | S-8 | 0001193125-26-161725 | 333-295164 | 26872365 | 33 | 199555 | 1 | 1 | |
| 2026-04-10 | 10-K | 10-K | 0001193125-26-151364 | 001-38890 | 26855392 | 34 | 16792188 | 1 | 1 | |
| 2026-04-09 | 8-K | 8-K | 3.03,5.03,9.01 | 0001193125-26-149021 | 001-38890 | 26850028 | 34 | 158123 | 1 | 1 |
| 2026-04-01 | NT 10-K | NT 10-K | 0001193125-26-138017 | 001-38890 | 26828692 | 34 | 21459 | |||
| 2026-03-30 | 8-K | 8-K | 1.02,7.01,9.01 | 0001193125-26-130489 | 001-38890 | 26810104 | 34 | 162164 | 1 | 1 |
| 2026-03-20 | 8-K | 8-K | 3.01 | 0001193125-26-117794 | 001-38890 | 26778807 | 34 | 144159 | 1 | 1 |
| 2026-03-05 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932540-26-000004 | 005-91007 | 26727700 | 34 | 7395 | |||
| 2026-02-12 | 8-K | 8-K | 2.02,8.01 | 0001193125-26-047544 | 001-38890 | 26623208 | 34 | 156031 | 1 | 1 |
| 2026-02-02 | 8-K | 8-K | 5.02 | 0001193125-26-033758 | 001-38890 | 26588315 | 34 | 135430 | 1 | 1 |
| 2026-01-29 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-029524 | 001-38890 | 26578763 | 34 | 169089 | 1 | 1 |
| 2026-01-23 | 4 | FORM 4 | 0000912282-26-000121 | 5618 | ||||||
| 2026-01-23 | 4 | FORM 4 | 0000912282-26-000120 | 5641 | ||||||
| 2026-01-23 | 4 | FORM 4 | 0000912282-26-000119 | 5605 | ||||||
| 2026-01-21 | 4 | FORM 4 | 0000912282-26-000089 | 5496 | ||||||
| 2026-01-21 | 4 | FORM 4 | 0000912282-26-000087 | 5499 | ||||||
| 2026-01-21 | 4 | FORM 4 | 0000912282-26-000085 | 5478 | ||||||
| 2026-01-21 | 4 | FORM 4 | 0000912282-26-000083 | 5472 | ||||||
| 2025-12-29 | 144 | xsl144X01/primary_doc.xml | 0001628280-25-059050 | 001-38890 | 251610551 | 33 | 4803 | |||
| 2025-12-29 | 4 | FORM 4 | 0000912282-25-001469 | 5502 | ||||||
| 2025-12-29 | 4 | FORM 4 | 0000912282-25-001468 | 5465 | ||||||
| 2025-12-12 | 4 | FORM 4 | 0000912282-25-001407 | 6008 | ||||||
| 2025-12-08 | 4 | FORM 4 | 0000912282-25-001370 | 10673 | ||||||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-112623 | 005-91007 | 251487222 | 34 | 11469 | |||
| 2025-11-12 | 10-Q | 10-Q | 0001193125-25-277529 | 001-38890 | 251472622 | 34 | 12841947 | 1 | 1 | |
| 2025-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-277523 | 001-38890 | 251472602 | 34 | 477084 | 1 | 1 |
| 2025-10-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001140361-25-039832 | 005-91007 | 251434295 | 34 | 15634 | |||
| 2025-10-17 | 8-K | 8-K | 7.01 | 0001193125-25-242514 | 001-38890 | 251400967 | 34 | 138806 | 1 | 1 |
| 2025-10-17 | 424B5 | 424B5 | 0001193125-25-242511 | 333-283897 | 251400955 | 33 | 71253 | |||
| 2025-09-26 | 8-K | 8-K | 1.01,2.03 | 0001193125-25-220722 | 001-38890 | 251351126 | 34 | 138825 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-078682 | 005-91007 | 251220055 | 34 | 11338 | |||
| 2025-08-11 | 10-Q | 10-Q | 0000950170-25-106535 | 001-38890 | 251202006 | 34 | 12653219 | 1 | 1 | |
| 2025-08-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-106536 | 001-38890 | 251201977 | 34 | 456895 | 1 | 1 |
| 2025-08-05 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002488 | 333-288971 | 251187228 | 33 | 1863 | ||
| 2025-08-05 | 424B5 | 424B5 | 0001193125-25-173623 | 333-288971 | 251186171 | 33 | 233350 | |||
| 2025-08-01 | CORRESP | filename1.htm | 0001193125-25-171664 | 6508 | ||||||
| 2025-08-01 | UPLOAD | filename1.pdf | 0000000000-25-008116 | 333-288971 | 40271 | |||||
| 2025-07-25 | S-3 | S-3 | 0001193125-25-165524 | 333-288971 | 251152333 | 33 | 336338 | |||
| 2025-07-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-159886 | 001-38890 | 251127761 | 34 | 186782 | 1 | 1 |
| 2025-07-01 | D | xslFormDX01/primary_doc.xml | 06b | 0001662774-25-000035 | 021-550459 | 251095659 | 33 | 15724 | ||
| 2025-06-23 | 4 | xslF345X05/form4.xml | 0000912282-25-000697 | 6354 | ||||||
| 2025-06-23 | 4 | xslF345X05/form4.xml | 0000912282-25-000696 | 6386 | ||||||
| 2025-06-23 | 4 | xslF345X05/form4.xml | 0000912282-25-000695 | 6372 | ||||||
| 2025-06-13 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-25-140873 | 001-38890 | 251047764 | 34 | 827459 | 1 | 1 |
| 2025-06-06 | 4 | xslF345X05/form4.xml | 0000912282-25-000625 | 5272 | ||||||
| 2025-06-06 | 4 | xslF345X05/form4.xml | 0000912282-25-000623 | 5793 | ||||||
| 2025-06-06 | 4 | xslF345X05/form4.xml | 0000912282-25-000621 | 5311 | ||||||
| 2025-06-06 | 4 | xslF345X05/form4.xml | 0000912282-25-000619 | 5317 | ||||||
| 2025-06-06 | 4 | xslF345X05/form4.xml | 0000912282-25-000617 | 5338 | ||||||
| 2025-06-06 | 4 | xslF345X05/form4.xml | 0000912282-25-000615 | 5326 | ||||||
| 2025-06-06 | 4 | xslF345X05/form4.xml | 0000912282-25-000613 | 5310 | ||||||
| 2025-06-05 | 8-K | 8-K | 5.07 | 0001662774-25-000034 | 001-38890 | 251027236 | 34 | 163375 | 1 | 1 |
| 2025-05-13 | 10-Q | 10-Q | 0001662774-25-000032 | 001-38890 | 25937387 | 34 | 7148031 | 1 | 1 | |
| 2025-05-13 | 8-K | 8-K | 2.02,9.01 | 0001662774-25-000031 | 001-38890 | 25937229 | 34 | 250280 | 1 | 1 |
| 2025-04-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-042498 | 005-91007 | 25894995 | 34 | 29991 | |||
| 2025-04-23 | ARS | ARS | 0001662774-25-000027 | 001-38890 | 25861478 | 34 | 27634813 | |||
| 2025-04-23 | DEFA14A | DEFA14A | 0001662774-25-000026 | 001-38890 | 25861360 | 34 | 11403209 | |||
| 2025-04-23 | DEF 14A | DEF 14A | 0001662774-25-000025 | 001-38890 | 25861329 | 34 | 2476696 | 1 | 1 | |
| 2025-04-09 | PRE 14A | PRE 14A | 0001662774-25-000016 | 001-38890 | 25825176 | 34 | 2500039 | 1 | 1 | |
| 2025-03-24 | S-8 | S-8 | 0001193125-25-061463 | 333-286063 | 25765130 | 33 | 90435 | |||
| 2025-03-24 | 424B5 | 424B5 | 0001193125-25-061458 | 333-283897 | 25765090 | 33 | 19021 | |||
| 2025-03-24 | 10-K | 10-K | 0001662774-25-000012 | 001-38890 | 25764226 | 34 | 13476720 | 1 | 1 | |
| 2025-03-24 | 8-K | 8-K | 2.02,9.01 | 0001662774-25-000011 | 001-38890 | 25764199 | 34 | 263486 | 1 | 1 |
| 2025-02-18 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001140361-25-004984 | 005-91007 | 25634158 | 34 | 12771 | |||
| 2025-02-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-014182 | 005-91007 | 25629562 | 34 | 29611 | |||
| 2025-02-11 | 4 | xslF345X05/form4-02112025_100234.xml | 0001415889-25-003618 | 5699 | ||||||
| 2025-02-11 | 4 | xslF345X05/form4-02112025_100214.xml | 0001415889-25-003615 | 5760 | ||||||
| 2025-02-11 | 4 | xslF345X05/form4-02112025_100238.xml | 0001415889-25-003613 | 5705 | ||||||
| 2025-01-08 | 4 | xslF345X05/form4-01092025_120123.xml | 0001415889-25-001164 | 5701 | ||||||
| 2025-01-08 | 4 | xslF345X05/form4-01092025_120106.xml | 0001415889-25-001163 | 5683 | ||||||
| 2025-01-08 | 4 | xslF345X05/form4-01092025_120154.xml | 0001415889-25-001162 | 5687 | ||||||
| 2025-01-08 | 4 | xslF345X05/form4-01092025_120111.xml | 0001415889-25-001160 | 5672 | ||||||
| 2024-12-27 | 424B5 | 424B5 | 0001628280-24-052494 | 333-283897 | 241585703 | 33 | 184499 | |||
| 2024-12-26 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-24-003919 | 333-283897 | 241582132 | 33 | 1870 | ||
| 2024-12-23 | CORRESP | filename1.htm | 0001662774-24-000018 | 8714 | ||||||
| 2024-12-23 | UPLOAD | filename1.pdf | 0000000000-24-014218 | 333-283897 | 40297 | |||||
| 2024-12-18 | S-3 | S-3 | 0001628280-24-051856 | 333-283897 | 241559157 | 33 | 1535464 | |||
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 2 | 0001214659-24-019112 | 005-91007 | 241461367 | 34 | 83953 | |||
| 2024-11-14 | 8-K | 8-K | 8.01 | 0001662774-24-000013 | 001-38890 | 241457034 | 34 | 151794 | 1 | 1 |
| 2024-11-13 | SC 13D | SC 13D | 0001193125-24-257646 | 005-91007 | 241456564 | 34 | 56238 | |||
| 2024-11-13 | 10-Q | 10-Q | 0001662774-24-000011 | 001-38890 | 241455572 | 34 | 11059038 | 1 | 1 | |
| 2024-11-13 | 8-K | 8-K | 2.02,9.01 | 0001662774-24-000010 | 001-38890 | 241454412 | 34 | 275544 | 1 | 1 |
| 2024-09-03 | 4 | xslF345X05/form4-09032024_090940.xml | 0001415889-24-022702 | 6945 | ||||||
| 2024-08-22 | 4 | xslF345X05/form4-08222024_090813.xml | 0001415889-24-022054 | 5245 | ||||||
| 2024-08-21 | 4 | xslF345X05/form4-08212024_100803.xml | 0001415889-24-021869 | 12053 | ||||||
| 2024-08-13 | 10-Q | 10-Q | 0001662774-24-000005 | 001-38890 | 241201562 | 34 | 10985070 | 1 | 1 | |
| 2024-08-13 | 8-K | 8-K | 2.02,9.01 | 0001662774-24-000004 | 001-38890 | 241201517 | 34 | 281548 | 1 | 1 |
| 2024-08-06 | SC 13G/A | SC 13G/A | 0001104659-24-086395 | 005-91007 | 241181035 | 34 | 161503 | |||
| 2024-06-21 | 8-K | 8-K | 3.01 | 0001193125-24-165631 | 001-38890 | 241060083 | 34 | 147655 | 1 | 1 |
| 2024-06-07 | 4 | xslF345X05/form4-06082024_010656.xml | 0001415889-24-016093 | 5570 | ||||||
| 2024-06-07 | 4 | xslF345X05/form4-06082024_010616.xml | 0001415889-24-016092 | 5591 | ||||||
| 2024-06-07 | 4 | xslF345X05/form4-06082024_010657.xml | 0001415889-24-016091 | 5525 | ||||||
| 2024-06-07 | 4 | xslF345X05/form4-06082024_010651.xml | 0001415889-24-016090 | 5564 | ||||||
| 2024-06-07 | 4 | xslF345X05/form4-06082024_120627.xml | 0001415889-24-016089 | 5563 | ||||||
| 2024-06-07 | 4 | xslF345X05/form4-06082024_120618.xml | 0001415889-24-016088 | 6046 | ||||||
| 2024-06-07 | 4 | xslF345X05/form4-06082024_120623.xml | 0001415889-24-016087 | 5579 | ||||||
| 2024-06-06 | 8-K | 8-K | 5.07 | 0001193125-24-156202 | 001-38890 | 241026432 | 34 | 155943 | 1 | 1 |
| 2024-06-05 | 4 | xslF345X05/form4-06052024_060635.xml | 0001415889-24-015533 | 7137 | ||||||
| 2024-05-13 | 10-Q | 10-Q | 0000950170-24-058201 | 001-38890 | 24936880 | 34 | 14065531 | 1 | 1 | |
| 2024-04-24 | ARS | ARS | 0001193125-24-110094 | 001-38890 | 24870687 | 34 | 6831553 | |||
| 2024-04-24 | DEFA14A | DEFA14A | 0001193125-24-110058 | 001-38890 | 24870564 | 34 | 807370 | |||
| 2024-04-24 | DEF 14A | DEF 14A | 0001193125-24-110034 | 001-38890 | 24870488 | 34 | 4059455 | 1 | 1 | |
| 2024-04-11 | PRE 14A | PRE 14A | 0001193125-24-093305 | 001-38890 | 24838982 | 34 | 3964733 | 1 | 1 | |
| 2024-04-01 | S-8 | S-8 | 0001193125-24-083605 | 333-278440 | 24811038 | 33 | 85460 | |||
| 2024-04-01 | 10-K | 10-K | 0000950170-24-039440 | 001-38890 | 24810353 | 34 | 20712373 | 1 | 1 | |
| 2024-02-15 | 4 | xslF345X05/form4-02152024_110201.xml | 0001415889-24-003984 | 5707 | ||||||
| 2024-02-15 | 3 | xslF345X02/form3-02152024_110211.xml | 0001415889-24-003981 | 11744 | ||||||
| 2024-02-15 | 8-K | 8-K | 5.02 | 0001193125-24-037521 | 001-38890 | 24643681 | 34 | 185653 | 1 | 1 |
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-002876 | 005-91007 | 24637381 | 34 | 83345 | |||
| 2024-02-12 | SC 13G | SC 13G | 0001104659-24-013830 | 005-91007 | 24617580 | 34 | 162787 | |||
| 2024-02-07 | SC 13G/A | qncx13g020724.htm | 0001616824-24-000021 | 005-91007 | 24602800 | 34 | 82577 | |||
| 2024-02-02 | 4 | xslF345X05/form4-02022024_110255.xml | 0001415889-24-002380 | 5760 | ||||||
| 2024-02-02 | 4 | xslF345X05/form4-02022024_100258.xml | 0001415889-24-002379 | 5719 | ||||||
| 2024-02-02 | 4 | xslF345X05/form4-02022024_100215.xml | 0001415889-24-002378 | 5700 | ||||||
| 2024-01-29 | 8-K | 8-K | 5.02 | 0001193125-24-018071 | 001-38890 | 24573525 | 34 | 189173 | 1 | 1 |
| 2024-01-17 | 4 | xslF345X05/form4-01172024_090120.xml | 0001415889-24-001313 | 11073 | ||||||
| 2024-01-05 | 8-K/A | 8-K/A | 9.01 | 0001193125-24-003344 | 001-38890 | 24516165 | 34 | 1141301 | 1 | 1 |
| 2024-01-03 | 8-K | 8-K | 8.01 | 0001193125-24-001482 | 001-38890 | 24506199 | 34 | 182645 | 1 | 1 |
| 2023-12-22 | 8-K | 8-K | 1.02 | 0001193125-23-302116 | 001-38890 | 231509859 | 34 | 204286 | 1 | 1 |
| 2023-12-15 | SC 13G | SC 13G | 0001140361-23-057682 | 005-91007 | 231488214 | 34 | 128730 | |||
| 2023-12-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-058694 | 12524 | ||||||
| 2023-12-08 | 8-K | 8-K | 3.01 | 0001193125-23-291671 | 001-38890 | 231475431 | 34 | 202952 | 1 | 1 |
| 2023-12-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-057799 | 10532 | ||||||
| 2023-12-01 | 4 | FORM 4 SUBMISSION | 0001209191-23-057053 | 11531 | ||||||
| 2023-11-14 | 10-Q | 10-Q | 0000950170-23-063716 | 001-38890 | 231406456 | 34 | 13174602 | 1 | 1 | |
| 2023-10-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-053695 | 5537 | ||||||
| 2023-10-26 | 8-K | 8-K | 5.02 | 0001193125-23-264057 | 001-38890 | 231350083 | 34 | 184692 | 1 | 1 |
| 2023-10-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-053510 | 6122 | ||||||
| 2023-10-24 | 3 | FORM 3 SUBMISSION | 0001209191-23-053509 | 8023 | ||||||
| 2023-10-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-053508 | 5775 | ||||||
| 2023-10-24 | 3 | FORM 3 SUBMISSION | 0001209191-23-053505 | 7610 | ||||||
| 2023-10-23 | 8-K | 8-K | 1.01,2.01,2.03,5.02,9.01 | 0001193125-23-260785 | 001-38890 | 231340061 | 34 | 200524 | 1 | 1 |
| 2023-09-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-048483 | 5659 | ||||||
| 2023-09-06 | 3 | FORM 3 SUBMISSION | 0001209191-23-048477 | 7636 | ||||||
| 2023-09-06 | 8-K | 8-K | 1.01,2.03,5.02 | 0001193125-23-229101 | 001-38890 | 231237847 | 34 | 194439 | 1 | 1 |
| 2023-08-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-047880 | 9359 | ||||||
| 2023-08-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-046402 | 11574 | ||||||
| 2023-08-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-045432 | 5146 | ||||||
| 2023-08-10 | 8-K | 8-K | 5.02 | 0001193125-23-209172 | 001-38890 | 231160541 | 34 | 184740 | 1 | 1 |
| 2023-08-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-045235 | 5136 | ||||||
| 2023-08-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-045234 | 5156 | ||||||
| 2023-08-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-045231 | 5193 | ||||||
| 2023-08-03 | 10-Q | 10-Q | 0000950170-23-038042 | 001-38890 | 231140383 | 34 | 12920967 | 1 | 1 | |
| 2023-07-24 | 8-K | 8-K | 1.01,2.02,2.03,3.02,5.02,7.01,8.01,9.01 | 0001193125-23-191839 | 001-38890 | 231103739 | 34 | 10619448 | 1 | 1 |
| 2023-07-17 | SC 13G | NONE | 0001567619-23-006604 | 005-91007 | 231090860 | 34 | 82693 | |||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032681 | 9341 | ||||||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032679 | 9278 | ||||||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032677 | 9367 | ||||||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032674 | 9340 | ||||||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032671 | 9357 | ||||||
| 2023-05-25 | 8-K | 8-K | 5.07 | 0001193125-23-154245 | 001-38890 | 23960968 | 34 | 194091 | 1 | 1 |
| 2023-05-15 | 10-Q | 10-Q | 0000950170-23-022241 | 001-38890 | 23923017 | 34 | 12741561 | 1 | 1 | |
| 2023-04-14 | ARS | ARS | 0001193125-23-102069 | 001-38890 | 23821281 | 34 | 1827462 | |||
| 2023-04-14 | DEFA14A | DEFA14A | 0001193125-23-102054 | 001-38890 | 23821231 | 34 | 508844 | |||
| 2023-04-14 | DEF 14A | DEF 14A | 0001193125-23-102037 | 001-38890 | 23821168 | 34 | 4358050 | 1 | 1 | |
| 2023-04-05 | 8-A12B | 8-A12B | 0001193125-23-092432 | 001-38890 | 23803485 | 34 | 16896 | |||
| 2023-04-05 | 8-K | 8-K | 1.01,3.03,5.03,8.01,9.01 | 0001193125-23-092414 | 001-38890 | 23803395 | 34 | 556878 | 1 | 1 |
| 2023-04-04 | PRE 14A | PRE 14A | 0001193125-23-090937 | 001-38890 | 23798332 | 34 | 4358856 | 1 | 1 | |
| 2023-03-31 | SC 13G | r322230sc13g.htm | 0001214659-23-004596 | 005-91007 | 23787326 | 34 | 91117 | |||
| 2023-03-28 | 8-K | 8-K | 5.02 | 0001193125-23-082305 | 001-38890 | 23770444 | 34 | 142742 | 1 | 1 |
| 2023-03-15 | S-8 | S-8 | 0001193125-23-071454 | 333-270577 | 23736061 | 33 | 78753 | |||
| 2023-03-15 | 10-K | 10-K | 0000950170-23-008148 | 001-38890 | 23735425 | 34 | 15708203 | 1 | 1 | |
| 2023-03-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-016507 | 5038 | ||||||
| 2023-03-03 | 8-K | 8-K | 5.02 | 0001193125-23-060044 | 001-38890 | 23704114 | 34 | 145866 | 1 | 1 |
| 2023-02-13 | SC 13G/A | QNCX_13G_A4 | 0001779453-23-000006 | 005-91007 | 23620190 | 34 | 77248 | |||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-006402 | 5657 | ||||||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-006401 | 5726 | ||||||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-006398 | 5694 | ||||||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-006394 | 5677 | ||||||
| 2023-01-30 | 8-K | 8-K | 2.02,2.05,8.01 | 0001193125-23-019103 | 001-38890 | 23568015 | 34 | 160726 | 1 | 1 |
| 2023-01-27 | 8-K | 8-K | 1.01,5.02 | 0001193125-23-017549 | 001-38890 | 23562990 | 34 | 158595 | 1 | 1 |
| 2022-12-16 | 8-K | 8-K | 3.01 | 0001193125-22-307303 | 001-38890 | 221467937 | 34 | 145258 | 1 | 1 |
| 2022-12-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-060218 | 5039 | ||||||
| 2022-11-09 | 10-Q | 10-Q | 0000950170-22-023877 | 001-38890 | 221372857 | 34 | 13098908 | 1 | 1 | |
| 2022-09-30 | 8-K | 8-K | 5.02 | 0001193125-22-255696 | 001-38890 | 221284852 | 34 | 143858 | 1 | 1 |
| 2022-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-049221 | 5039 | ||||||
| 2022-08-09 | 10-Q | 10-Q | 0000950170-22-016102 | 001-38890 | 221148724 | 34 | 16300383 | 1 | 1 | |
| 2022-08-01 | 8-K | 8-K | 2.02,5.03,8.01,9.01 | 0001193125-22-207867 | 001-38890 | 221123037 | 34 | 393845 | 1 | 1 |
| 2022-07-22 | 8-K | 8-K | 5.02 | 0001193125-22-200068 | 001-38890 | 221100189 | 34 | 178351 | 1 | 1 |
| 2022-07-08 | SC 13G/A | SEC SCHEDULE 13G | 0001422849-22-000154 | 005-91007 | 221073668 | 34 | 18154 | |||
| 2022-07-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-040306 | 9164 | ||||||
| 2022-06-10 | 8-K | 8-K | 1.01,2.03,5.02,5.07 | 0001193125-22-172060 | 001-38890 | 221009718 | 34 | 166406 | 1 | 1 |
| 2022-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-035877 | 5295 | ||||||
| 2022-06-10 | 3 | FORM 3 SUBMISSION | 0001209191-22-035870 | 6748 | ||||||
| 2022-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-035678 | 5288 | ||||||
| 2022-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-035674 | 5249 | ||||||
| 2022-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-035672 | 5297 | ||||||
| 2022-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-035671 | 5315 | ||||||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-035020 | 4914 | ||||||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-035017 | 5433 | ||||||
| 2022-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-035014 | 6942 | ||||||
| 2022-05-27 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-032677 | 5791 | ||||||
| 2022-05-27 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-032675 | 5722 | ||||||
| 2022-05-27 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-032672 | 5742 | ||||||
| 2022-05-25 | DEFA14A | DEFA14A | 0001193125-22-159688 | 001-38890 | 22962944 | 34 | 26342 | |||
| 2022-05-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-031515 | 10179 | ||||||
| 2022-05-23 | 3 | FORM 3 SUBMISSION | 0001209191-22-031511 | 6758 | ||||||
| 2022-05-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-031508 | 10248 | ||||||
| 2022-05-23 | 3 | FORM 3 SUBMISSION | 0001209191-22-031506 | 6844 | ||||||
| 2022-05-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-031503 | 9295 | ||||||
| 2022-05-23 | 3 | FORM 3 SUBMISSION | 0001209191-22-031502 | 6725 | ||||||
| 2022-05-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-031500 | 7236 | ||||||
| 2022-05-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-031498 | 10196 | ||||||
| 2022-05-23 | 3 | FORM 3 SUBMISSION | 0001209191-22-031493 | 6798 | ||||||
| 2022-05-20 | S-8 | S-8 | 0001193125-22-156129 | 333-265109 | 22947613 | 33 | 387170 | |||
| 2022-05-20 | 8-K | 8-K | 2.01,5.02 | 0001193125-22-155640 | 001-38890 | 22945328 | 34 | 145493 | 1 | 1 |
| 2022-05-19 | 424B5 | 424B5 | 0001193125-22-155097 | 333-238851 | 22943736 | 33 | 133453 | |||
| 2022-05-17 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001193125-22-066056,2022-05-17 | 9999999995-22-001501 | 333-238851 | 22936934 | 33 | 1701 | ||
| 2022-05-17 | POS EX | POS EX | 0001193125-22-152218 | 333-238851 | 22931941 | 33 | 77790 | |||
| 2022-05-12 | 8-K | 8-K | 1.01,2.02,3.02,5.02,9.01 | 0001193125-22-148822 | 001-38890 | 22918942 | 34 | 936041 | 1 | 1 |
| 2022-05-10 | 10-Q | 10-Q | 0000950170-22-009040 | 001-38890 | 22910637 | 34 | 9507248 | 1 | 1 | |
| 2022-05-10 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-145747 | 001-38890 | 22907467 | 34 | 170793 | 1 | 1 |
| 2022-05-02 | 8-K | 8-K | 2.05,5.02 | 0001193125-22-137040 | 001-38890 | 22883366 | 34 | 144716 | 1 | 1 |
| 2022-04-27 | DEFA14A | DEFA14A | 0001193125-22-123573 | 001-38890 | 22859458 | 34 | 620145 | |||
| 2022-04-27 | DEF 14A | DEF 14A | 0001193125-22-123565 | 001-38890 | 22859438 | 34 | 1518126 | |||
| 2022-03-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-019311 | 5307 | ||||||
| 2022-03-16 | 3 | FORM 3 SUBMISSION | 0001209191-22-019305 | 6735 | ||||||
| 2022-03-15 | 8-K | 8-K | 5.02 | 0001193125-22-076267 | 001-38890 | 22742128 | 34 | 143688 | 1 | 1 |
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016443 | 4967 | ||||||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016441 | 4929 | ||||||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016440 | 4964 | ||||||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016429 | 4990 | ||||||
| 2022-03-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-016428 | 4986 | ||||||
| 2022-03-04 | POS AM | POS AM | 0001193125-22-066056 | 333-238851 | 22714017 | 33 | 401263 | |||
| 2022-03-01 | S-8 | S-8 | 0001193125-22-061705 | 333-263186 | 22699938 | 33 | 80331 | |||
| 2022-03-01 | 10-K | 10-K | 0000950170-22-002571 | 001-38890 | 22699367 | 34 | 13358389 | 1 | 1 | |
| 2022-02-14 | SC 13G/A | SC 13G/A 3 CORTEXYME | 0000078003-22-000018 | 005-91007 | 22623350 | 34 | 76994 | |||
| 2022-02-11 | SC 13G/A | SEC SCHEDULE 13G | 0001422849-22-000060 | 005-91007 | 22619662 | 34 | 18133 | |||
| 2022-02-11 | SC 13G/A | SEC SCHEDULE 13G | 0001422848-22-000169 | 005-91007 | 22618501 | 34 | 18129 | |||
| 2022-02-07 | POSASR | POSASR | 0001193125-22-029752 | 333-238851 | 22598351 | 33 | 786510 | |||
| 2022-02-02 | 8-K | 8-K | 2.02,2.05,5.02,8.01 | 0001193125-22-025869 | 001-38890 | 22584549 | 34 | 168948 | 1 | 1 |
| 2022-01-26 | 8-K | 8-K | 8.01 | 0001193125-22-017740 | 001-38890 | 22555739 | 34 | 145211 | 1 | 1 |
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-001824 | 5522 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-001792 | 5478 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-001788 | 5520 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-001759 | 5523 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-001754 | 5538 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-001752 | 5535 | ||||||
| 2022-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-001731 | 5327 | ||||||
| 2021-12-23 | 8-K | 8-K | 1.01,9.01 | 0001193125-21-366374 | 001-38890 | 211518189 | 34 | 400729 | 1 | 1 |
| 2021-12-23 | 424B5 | 424B5 | 0001193125-21-366368 | 333-238851 | 211518169 | 33 | 279145 | |||
| 2021-12-10 | SC 13G/A | SEC SCHEDULE 13G | 0001562230-21-000135 | 005-91007 | 211485371 | 34 | 18243 | |||
| 2021-12-10 | SC 13G/A | SEC SCHEDULE 13G | 0001562230-21-000137 | 005-91007 | 211484874 | 34 | 18243 | |||
| 2021-11-19 | 4 | FORM 4 SUBMISSION | 0001209191-21-065993 | 9261 | ||||||
| 2021-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-21-064924 | 7010 | ||||||
| 2021-11-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-064346 | 5990 | ||||||
| 2021-10-29 | 10-Q | 10-Q | 0000950170-21-002495 | 001-38890 | 211360940 | 34 | 8898065 | 1 | 1 | |
| 2021-10-26 | 8-K | 8-K | 8.01 | 0001193125-21-307962 | 001-38890 | 211348527 | 34 | 151014 | 1 | 1 |
| 2021-10-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-060264 | 8682 | ||||||
| 2021-10-08 | SC 13G/A | SEC SCHEDULE 13G | 0001562230-21-000134 | 005-91007 | 211314524 | 34 | 18245 | |||
| 2021-10-08 | SC 13G/A | SEC SCHEDULE 13G | 0001562230-21-000132 | 005-91007 | 211314503 | 34 | 18245 | |||
| 2021-10-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-059984 | 8627 | ||||||
| 2021-08-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-052285 | 16913 | ||||||
| 2021-08-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-052277 | 20655 | ||||||
| 2021-08-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-051214 | 8757 | ||||||
| 2021-08-06 | 10-Q | 10-Q | 0000950170-21-001015 | 001-38890 | 211153231 | 34 | 9215286 | 1 | 1 | |
| 2021-07-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-045948 | 26853 | ||||||
| 2021-06-30 | 4 | FORM 4 SUBMISSION | 0001209191-21-044027 | 19098 | ||||||
| 2021-06-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-043707 | 7837 | ||||||
| 2021-06-21 | 8-K | 8-K | 5.07 | 0001193125-21-193522 | 001-38890 | 211026847 | 34 | 154765 | 1 | 1 |
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041719 | 5290 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041716 | 5251 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041714 | 5317 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041711 | 5299 | ||||||
| 2021-05-18 | 8-K | 8-K | 1.01,2.03 | 0001193125-21-165311 | 001-38890 | 21935982 | 34 | 141649 | 1 | 1 |
| 2021-05-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-032078 | 13725 | ||||||
| 2021-05-06 | 10-Q | 10-Q | 0001564590-21-025001 | 001-38890 | 21898075 | 34 | 8147987 | 1 | 1 | |
| 2021-04-30 | DEFA14A | DEFA14A | 0001193125-21-144941 | 001-38890 | 21877679 | 34 | 294815 | |||
| 2021-04-30 | DEF 14A | DEF 14A | 0001193125-21-141486 | 001-38890 | 21873099 | 34 | 1979831 | |||
| 2021-04-27 | SC 13G/A | SC 13G/A | 0001193125-21-133435 | 005-91007 | 21856845 | 34 | 35955 | |||
| 2021-03-25 | SC 13G/A | CORTEXYME SC 13G/A 2 | 0000078003-21-000051 | 005-91007 | 21772590 | 34 | 68030 | |||
| 2021-03-24 | 4 | FORM 4 SUBMISSION | 0001209191-21-022947 | 6966 | ||||||
| 2021-03-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-022688 | 6778 | ||||||
| 2021-03-23 | 4 | FORM 4 SUBMISSION | 0001209191-21-022682 | 13200 | ||||||
| 2021-03-10 | SC 13G/A | SEC SCHEDULE 13G | 0001422849-21-000132 | 005-91007 | 21729191 | 34 | 18102 | |||
| 2021-03-05 | 4 | FORM 4 SUBMISSION | 0001209191-21-018328 | 12644 | ||||||
| 2021-03-01 | S-8 | S-8 | 0001193125-21-063853 | 333-253743 | 21699493 | 33 | 68145 | |||
| 2021-03-01 | 10-K | 10-K | 0001564590-21-009867 | 001-38890 | 21697960 | 34 | 11640739 | 1 | ||
| 2021-02-16 | SC 13G | SEC SCHEDULE 13G | 0001562230-21-000041 | 005-91007 | 21636273 | 34 | 18184 | |||
| 2021-02-16 | SC 13G | SEC SCHEDULE 13G | 0001562230-21-000024 | 005-91007 | 21635929 | 34 | 18184 | |||
| 2021-02-16 | SC 13G/A | SEC SCHEDULE 13G | 0001422848-21-000043 | 005-91007 | 21635436 | 34 | 18146 | |||
| 2021-02-16 | SC 13G | SEC SCHEDULE 13G | 0001422849-21-000043 | 005-91007 | 21635014 | 34 | 18069 | |||
| 2021-02-16 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-043200 | 001-38890 | 21632054 | 34 | 162388 | 1 | 1 |
| 2021-02-16 | SC 13G/A | CORTEXYME SC 13G/A | 0000078003-21-000028 | 005-91007 | 21630117 | 34 | 66295 | |||
| 2021-02-11 | 4 | FORM 4 SUBMISSION | 0001209191-21-009949 | 5443 | ||||||
| 2021-02-11 | 3 | FORM 3 SUBMISSION | 0001209191-21-009947 | 10308 | ||||||
| 2021-02-11 | 4 | FORM 4 SUBMISSION | 0001209191-21-009920 | 5454 | ||||||
| 2021-02-10 | 8-K | 8-K | 5.02 | 0001193125-21-036344 | 001-38890 | 21614353 | 34 | 145324 | 1 | 1 |
| 2021-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-007540 | 42842 | ||||||
| 2021-02-01 | 5 | PRIMARY DOCUMENT | 0001779453-21-000001 | 4883 | ||||||
| 2021-02-01 | SC 13G/A | CRTX13GA3 | 0001771620-21-000001 | 005-91007 | 21576993 | 34 | 77117 | |||
| 2021-01-29 | SC 13G/A | SC 13G/A | 0001395064-21-000016 | 005-91007 | 21566999 | 34 | 128083 | |||
| 2021-01-26 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-21-017064 | 001-38890 | 21551765 | 34 | 172770 | 1 | 1 |
| 2021-01-25 | 8-K | 8-K | 5.02 | 0001193125-21-016445 | 001-38890 | 21550729 | 34 | 22155 | ||
| 2020-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-063615 | 22106 | ||||||
| 2020-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-063609 | 12387 | ||||||
| 2020-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-063604 | 12420 | ||||||
| 2020-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-063602 | 12427 | ||||||
| 2020-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-063601 | 12392 | ||||||
| 2020-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-063600 | 8485 | ||||||
| 2020-12-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-063277 | 10908 | ||||||
| 2020-12-04 | 8-K | 8-K | 8.01 | 0001193125-20-310020 | 001-38890 | 201368721 | 34 | 21825 | ||
| 2020-11-12 | 10-Q | 10-Q | 0001564590-20-053571 | 001-38890 | 201306886 | 34 | 7524056 | 1 | ||
| 2020-08-14 | 10-Q | 10-Q | 0001564590-20-040300 | 001-38890 | 201105529 | 34 | 7769383 | 1 | ||
| 2020-06-15 | 4 | PRIMARY DOCUMENT | 0001779453-20-000005 | 8637 | ||||||
| 2020-06-10 | 8-K | 8-K | 5.07 | 0001193125-20-165699 | 001-38890 | 20954859 | 34 | 23971 | ||
| 2020-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-20-035425 | 9272 | ||||||
| 2020-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-20-035424 | 9296 | ||||||
| 2020-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-20-035423 | 9237 | ||||||
| 2020-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-20-035421 | 9319 | ||||||
| 2020-06-09 | 4 | FORM 4 SUBMISSION | 0001209191-20-035419 | 5378 | ||||||
| 2020-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-20-035104 | 13923 | ||||||
| 2020-06-04 | 4 | PRIMARY DOCUMENT | 0000078003-20-000038 | 8553 | ||||||
| 2020-06-01 | S-3ASR | S-3ASR | 0001193125-20-157335 | 333-238851 | 20933947 | 33 | 671201 | |||
| 2020-05-29 | 4 | FORM 4 SUBMISSION | 0001209191-20-032970 | 10913 | ||||||
| 2020-05-22 | 4 | PRIMARY DOCUMENT | 0001779453-20-000002 | 11716 | ||||||
| 2020-05-21 | 8-K | 8-K | 5.02,9.01 | 0001193125-20-148723 | 001-38890 | 20902275 | 34 | 73108 | ||
| 2020-05-19 | 4 | FORM 4 SUBMISSION | 0001209191-20-030688 | 22143 | ||||||
| 2020-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-030022 | 5418 | ||||||
| 2020-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-030020 | 5361 | ||||||
| 2020-05-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-029819 | 5346 | ||||||
| 2020-05-15 | 3 | FORM 3 SUBMISSION | 0001209191-20-029809 | 6834 | ||||||
| 2020-05-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-140538 | 001-38890 | 20869712 | 34 | 77844 | ||
| 2020-05-12 | 10-Q | 10-Q | 0001564590-20-024670 | 001-38890 | 20869323 | 34 | 6784733 | 1 | ||
| 2020-04-30 | 8-K | 8-K | 5.02 | 0001193125-20-128936 | 001-38890 | 20836540 | 34 | 18900 | ||
| 2020-04-22 | DEFA14A | DEFA14A | 0001564590-20-017901 | 001-38890 | 20807891 | 34 | 147575 | |||
| 2020-04-22 | DEF 14A | DEF 14A | 0001564590-20-017899 | 001-38890 | 20807877 | 34 | 908115 | |||
| 2020-04-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2020-04-13 16:00:00 | 9999999995-20-000739 | 333-237594 | 20789980 | 33 | 1688 | ||
| 2020-04-13 | 424B3 | 424B3 | 0001193125-20-105265 | 333-237594 | 20788981 | 33 | 209124 | |||
| 2020-04-09 | CORRESP | filename1.htm | 0001193125-20-102554 | 14801 | ||||||
| 2020-04-08 | UPLOAD | filename1.pdf | 0000000000-20-003043 | 39817 | ||||||
| 2020-04-07 | S-1 | S-1 | 0001193125-20-100556 | 333-237594 | 20780405 | 33 | 308173 | |||
| 2020-04-06 | 4 | FORM 4 SUBMISSION | 0001209191-20-023626 | 7016 |
One latest value per concept from companyfacts (354 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 10.84M | 2026-11-05 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 64.00M | 2025-06-30 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 1.73M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-08-25 | 0001193125-26-364220 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.17M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-08-25 | 0001193125-26-364220 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 3.94M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-08-25 | 0001193125-26-364220 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 2.41M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-08-25 | 0001193125-26-364220 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 525.57 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-08-25 | 0001193125-26-364220 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 3,322.53 | 2026-11-18 | S-8 | 2026-11-19 | 0001193125-26-468531 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 3,322.53 | 2026-11-18 | S-8 | 2026-11-19 | 0001193125-26-468531 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 38.19M | 2026-11-18 | S-8 | 2026-11-19 | 0001193125-26-468531 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-18 | S-8 | 2026-11-19 | 0001193125-26-468531 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-07-28 | S-3 | 2026-07-31 | 0001193125-26-328769 | |||
| us-gaap | AccountsAndOtherReceivablesNetCurrent | Accounts and Other Receivables, Net, Current | USD | 500,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063716 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AccretionExpense | Accretion Expense | USD | 694,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009867 |
| us-gaap | AccruedIncomeTaxesNoncurrent | Accrued Income Taxes, Noncurrent | USD | 553,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 5.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 896,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 19,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -17,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 462.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 406.61M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 15.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 15.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 5.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | Assets | Assets | USD | 106.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 106.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 104.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 37,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 104.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value | USD | 54.31M | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 54.31M | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 104.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 65.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | BusinessAcquisitionsProFormaNetIncomeLoss | Business Acquisition, Pro Forma Net Income (Loss) | USD | -52.59M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | BusinessAcquisitionsProFormaRevenue | Business Acquisition, Pro Forma Revenue | USD | 262,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | BusinessCombinationAcquisitionRelatedCosts | Business Combination, Acquisition Related Costs | USD | 2.50M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | BusinessCombinationBargainPurchaseGainRecognizedAmount | Business Combination, Bargain Purchase, Gain Recognized, Amount | USD | 1.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | USD | -64.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | BusinessCombinationContingentConsiderationLiability | Business Combination, Contingent Consideration, Liability | USD | 56.69M | 2024-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityCurrent | Business Combination, Contingent Consideration, Liability, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityNoncurrent | Business Combination, Contingent Consideration, Liability, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents | USD | 10.59M | 2022-05-19 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets | USD | 1.04M | 2022-05-19 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable | USD | 1.73M | 2022-05-19 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities | USD | 532,000 | 2022-05-19 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill | USD | 5.90M | 2022-05-19 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment | USD | 279,000 | 2022-05-19 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet | Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net | USD | 15.68M | 2022-05-19 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | Cash | Cash | USD | 709,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | CashAcquiredFromAcquisition | Cash Acquired from Acquisition | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 39.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 21.81M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0000950170-24-058201 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 105.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 39.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 7.21M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-06 | 0000950170-21-001015 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 34.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 11.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 400,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0.03 | 2014-06-30 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002571 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 27,941 | 2014-06-30 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002571 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-011165 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 18.14M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 250.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 1.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 1.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -73.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 8.00M | 2019-01-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009867 | |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 241,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 8.57M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 8.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | -9,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 11.76M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DebtInstrumentFairValue | Debt Instrument, Fair Value Disclosure | USD | 18.03M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest | DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue | DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001193125-26-352201 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 3.70M | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 23,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 3.97M | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | USD | 11.94M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 7.67M | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 23,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | Security | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DeferredCompensationLiabilityCurrent | Deferred Compensation Liability, Current | USD | 3.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | DeferredFinanceCostsCurrentNet | Debt Issuance Costs, Current, Net | USD | 1.13M | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-06-12 | 0001564590-19-022340 | |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | -5.59M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | -5.59M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 109,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DeferredIncomeTaxLiabilitiesNet | Deferred Income Tax Liabilities, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 85.18M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 13.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 247,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008148 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 109,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 59.69M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 8.01M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsForeign | Deferred Tax Assets, Tax Credit Carryforwards, Foreign | USD | 229,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001193125-26-352201 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 2.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other | USD | 604,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 85.07M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 45,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 100 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | Depreciation | Depreciation | USD | 100,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 92,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -10.79 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.72 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-009040 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -10.79 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.04 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | 0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0.04 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | EffectiveIncomeTaxRateReconciliationGiltiAmount | EffectiveIncomeTaxRateReconciliationGiltiAmount | USD | 6.54M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | EffectiveIncomeTaxRateReconciliationGiltiPercent | EffectiveIncomeTaxRateReconciliationGiltiPercent | pure | -0.081 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent | pure | 0.083 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.008 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | -0.003 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.221 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.004 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | -211,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001662774-24-000011 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 54.00M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053571 | |
| us-gaap | EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense | Share-based Payment Arrangement, Expense, Tax Benefit | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0000950170-24-058201 |
| us-gaap | EquityMethodInvestments | Equity Method Investments | USD | 78,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001193125-26-352201 | |
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount | USD | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063716 | |
| us-gaap | EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount | USD | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063716 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | -21.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-009040 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-009040 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements | USD | 5.00M | 2024-07-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001662774-24-000011 |
| us-gaap | FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings | USD | -206,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009867 |
| us-gaap | FairValueOfAssetsAcquired | Fair Value of Assets Acquired | USD | 4.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | FairValueOptionChangesInFairValueGainLoss1 | Fair Value, Option, Changes in Fair Value, Gain (Loss) | USD | 21.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 70,000 | 2023-02-28 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 19,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023877 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 6,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) | USD | 36,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | 477,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | ForeignIncomeTaxExpenseBenefitContinuingOperations | Foreign Income Tax Expense (Benefit), Continuing Operations | USD | 68,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | 1.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | GainLossOnSaleOfBusiness | Gain (Loss) on Disposition of Business | USD | 1.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | GainLossOnSaleOfInvestments | Gain (Loss) on Sale of Investments | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001662774-24-000011 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -9,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 29.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | Goodwill | Goodwill | USD | 0 | 2024-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | GoodwillAcquiredDuringPeriod | Goodwill, Acquired During Period | USD | 16.93M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | GoodwillAndIntangibleAssetImpairment | Goodwill and Intangible Asset Impairment | USD | 825,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008148 |
| us-gaap | GoodwillForeignCurrencyTranslationGainLoss | Goodwill, Foreign Currency Translation Gain (Loss) | USD | -495,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | ImpairmentOfIntangibleAssetsExcludingGoodwill | Impairment of Intangible Assets (Excluding Goodwill) | USD | 67.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | ImpairmentOfIntangibleAssetsFinitelived | Impairment of Intangible Assets, Finite-lived | USD | 447,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | USD | 67.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -56.47M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -80.77M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | -24.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | IncomeLossIncludingPortionAttributableToNoncontrollingInterest | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax | USD | -72.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 200,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | -5.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | -403,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -16.96M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 194,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 681,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | 67,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0001662774-24-000005 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 1,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 17.85M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 311,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 3.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -12.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | IncreaseDecreaseInDeferredIncomeTaxes | Increase (Decrease) in Deferred Income Taxes | USD | 4.96M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | -1.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | -165,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-009040 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | -766,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -3.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | IndefiniteLivedIntangibleAssetsExcludingGoodwill | Indefinite-lived Intangible Assets (Excluding Goodwill) | USD | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063716 | |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | InterestExpense | Interest Expense | USD | 957,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009867 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 29,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | InvestmentIncomeAmortizationOfDiscount | Investment Income, Amortization of Discount | USD | 812,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-011165 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 1.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 2.19M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-011165 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 604,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 387,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009867 |
| us-gaap | LeaseCost | Lease, Cost | USD | 368,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 48,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 139,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001193125-26-217098 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 69,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 101,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-277529 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 128,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 125,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001193125-26-217098 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 108,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001193125-26-217098 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 65,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001193125-26-217098 | |
| us-gaap | Liabilities | Liabilities | USD | 28.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 106.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | LiabilitiesAssumed1 | Liabilities Assumed | USD | 9.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 7.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 20.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | LiabilityForUncertainTaxPositionsCurrent | Liability for Uncertainty in Income Taxes, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008148 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 11.76M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 11.05M | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 10.41M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-277529 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 118.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -47.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -36.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -67.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -67.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -67.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 | Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063716 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 107.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -107.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 266,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 100,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 445,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.30M | 2021-07-01 | 2021-07-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008148 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.091 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 28.00M | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-06-12 | 0001564590-19-022340 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 53,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | OtherAccruedLiabilitiesNoncurrent | Other Accrued Liabilities, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | OtherAssets | Other Assets | USD | 78,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001193125-26-352201 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 65,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 106,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | USD | -396,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax | USD | -42,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | -3.16M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax | USD | 5.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -655,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023877 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 556,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 255,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | OtherRestructuringCosts | Other Restructuring Costs | USD | 100,000 | 2023-01-31 | 2023-04-30 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 |
| us-gaap | OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023877 |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 263,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009867 |
| us-gaap | PaymentForContingentConsiderationLiabilityFinancingActivities | Payment for Contingent Consideration Liability, Financing Activities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | PaymentsForRepurchaseOfInitialPublicOffering | Payments for Repurchase of Initial Public Offering | USD | 34,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009867 |
| us-gaap | PaymentsForRepurchaseOfWarrants | Payments for Repurchase of Warrants | USD | 66,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 12,000 | 2018-01-01 | 2018-03-31 | 2019 | Q1 | 10-Q | 2019-06-12 | 0001564590-19-022340 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 64.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | PaymentsToAcquireBusinessesNetOfCashAcquired | Payments to Acquire Businesses, Net of Cash Acquired | USD | -8.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 85.72M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0001662774-24-000005 |
| us-gaap | PaymentsToAcquireNotesReceivable | Payments to Acquire Notes Receivable | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001662774-24-000011 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 71,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 1.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 538,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 80,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | PriorPeriodReclassificationAdjustment | Prior Period Reclassification Adjustment | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | ProceedsFromDivestitureOfBusinesses | Proceeds from Divestiture of Businesses | USD | 450,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | ProceedsFromDivestitureOfBusinessesNetOfCashDivested | Proceeds from Divestiture of Businesses, Net of Cash Divested | USD | 450,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002571 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 75.69M | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009867 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008148 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 250,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009867 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 12.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 89.73M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0001662774-24-000005 |
| us-gaap | ProceedsFromSaleOfProductiveAssets | Proceeds from Sale of Productive Assets | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002571 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -56.83M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 424,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042988 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 69,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 500,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063716 | |
| us-gaap | RedeemableNoncontrollingInterestEquityPreferredCarryingAmount | Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount | USD | 143.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | RepaymentsOfShortTermDebt | Repayments of Short-term Debt | USD | 5.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 18.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 0 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053571 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -527.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 20.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 500,000 | 2023-08-04 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 15.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost | Share-based Payment Arrangement, Accelerated Cost | USD | 100,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage | Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | pure | 0.5 | 2023-08-04 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 114,437 | 2018-07-15 | 2018-07-16 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053571 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities Paid | USD | 3.60M | 2022-01-01 | 2022-03-31 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023877 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.802 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-011165 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.019 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-011165 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 0.82 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 275,000 | 2022-02-28 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016102 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 300,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 11.10M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 2.35 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-16 | 0001564590-20-011165 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 2.12M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008148 |
| us-gaap | SharePrice | Share Price | USD/shares | 0.989 | 2023-10-20 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 65.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 96,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -65.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.368 | 2019-04-25 | 2020 | Q2 | 10-Q | 2020-08-14 | 0001564590-20-040300 | |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 1,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 104.99M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0000950170-22-002571 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 183,000 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-11 | 0000950170-25-106535 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Forfeitures | USD | 18,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 340,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | SupplementalUnemploymentBenefitsSeveranceBenefits | Supplemental Unemployment Benefits, Severance Benefits | USD | 1.90M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-009040 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 294,370 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 211,301.868 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 211,301.868 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | TradingSecurities | Debt Securities, Trading, and Equity Securities, FV-NI | USD | 86.23M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-15 | 0000950170-23-022241 | |
| us-gaap | TranslationAdjustmentFunctionalToReportingCurrencyGainLossReclassifiedToEarningsNetOfTax | Translation Adjustment Functional to Reporting Currency, Gain (Loss), Reclassified to Earnings, Net of Tax | USD | 5.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic | Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | USD | 3.12M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001193125-26-217098 |
| us-gaap | UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted | USD | 3.10M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001193125-26-217098 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 35.88M | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 37,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 31.51M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001662774-25-000012 |
| us-gaap | UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | USD | 24,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 500,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0000950170-24-039440 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | -6.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-10 | 0001193125-26-151364 |
| us-gaap | ValueAddedTaxReceivable | Value Added Tax Receivable | USD | 6.76M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-277529 | |
| us-gaap | ValueAddedTaxReceivableCurrent | Value Added Tax Receivable, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 | |
| us-gaap | ValueAddedTaxReceivableNoncurrent | Value Added Tax Receivable, Noncurrent | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-14 | 0001193125-26-352201 | |
| us-gaap | WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount | WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount | USD | 6.36M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001193125-26-217098 |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 694,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001193125-26-217098 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 6.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 30.13M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-009040 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 6.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460562 |